Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)

Taiwan · Delayed Price · Currency is TWD

76.60

-4.20 (-5.20%)

Mar 4, 2026, 12:57 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Biotechnology (Startups)	32.04M	18.92M	1.14M	1.14M	833.00K
Biotechnology (Startups) Growth	69.39%	1554.86%	0%	37.21%	235.89%
Total	32.04M	18.92M	1.14M	1.14M	833.00K
Total Growth	69.39%	1554.86%	0%	37.21%	235.89%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Taiwan	-	-	1.14M	1.14M	833.00K
Taiwan Growth	-	-	0%	37.21%	235.89%
Hong Kong and Mainland China	31.93M	18.92M	-	-	-
Hong Kong and Mainland China Growth	68.80%	-	-	-	-
Singapore	112.00K	-	-	-	-
Total	32.04M	18.92M	1.14M	1.14M	833.00K
Total Growth	69.39%	1554.86%	0%	37.21%	235.89%

Source: S&P Global Market Intelligence.